title: French multicentric evaluation of recombinant tissue factor (recombiplastin) for determination of prothrombin time.
abstract: Recombiplastin, a recombinant a human tissue factor, elaborated by Ortho Diagnostic Systems, produced by Baculovirus and relipidated with highly purified phospholipids, was tested as a new reagent for determining prothrombin time (PT) in a French multicentric study. Its intralaboratory performances, including sensitivity, repeatability, reproducibility and stability, were explored to establish whether its use would reduce the interlaboratory dispersion of PT values, and therefore improve the standardization of oral anticoagulant treatment. The 9 university hospital hematology laboratories involved in this study used the same type of instrument (KC 10). For 10 consecutive days, they determined PTS on a normal plasma pool, plasma dilutions of 1/2, 1/3 and 1/8, 3 identical lyophilized calibrated plasmas, as well as plasmas from 20 normal subjects, 50 patients on oral anticoagulant therapy with Recombiplastin which has an International Sensitivity Index (ISI) of 1, and 2 commercial thromboplastin extracts (ISI #1 or 2). In the patients on anticoagulants, factors VII, X and V were measured when results were conflicting. The intra and interlaboratory reproducibilities of Recombiplastin, calculated on the basis of either PTS expressed in seconds, or of the International Normalized Ratio (INR), were good, with coefficients of variation (CV) similar to those observed with the 5 other reagents used by the different laboratories (2% < CV < 8%). The stability of Recombiplastin was excellent, with no variation in PT after 72 h of incubation at 37 degrees C. A normal PT of 12 s was obtained with Recombiplastin, similar to the values found for the reagents with ISI #2.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Hospital Hematology Laboratory, Paris, France.
authors.forename: J
authors.initials: J
authors.lastname: Roussi
authors.forename: L
authors.initials: L
authors.lastname: Drouet
authors.forename: M
authors.initials: M
authors.lastname: Samama
authors.forename: P
authors.initials: P
authors.lastname: Sié
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000627:therapeutic use; D004355:Drug Stability; D005069:Evaluation Studies as Topic; D005602:France; D005612:Freeze Drying; D006801:Humans; D016014:Linear Models; D011517:Prothrombin Time; D011994:Recombinant Proteins; D012016:Reference Values; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D013925:Thromboplastin
chemical_list: D000925:Anticoagulants; D011994:Recombinant Proteins; D013925:Thromboplastin